Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

French team synthesizes novel compounds with antihypoxic/antiischemic activity

Aug. 20, 1998

GR-196429 is a potent and selective agonist at melatonin receptors

Aug. 20, 1998

Akzo Nobel claims antipsychotic piperidine derivatives

Aug. 19, 1998

Elan subsidiary obtains patent rights for Cytel's integrin-blocking antibodies

Aug. 19, 1998

The Medicines Company acquires clinical-stage antimigraine drug for development

Aug. 18, 1998

Eisai files for Japanese approval of AD treatment agent

Aug. 17, 1998

Gidazepam, a new benzodiazepine anxiolytic with potential in asthenic disorders

Aug. 17, 1998

Unique agent for cognition disorders: GTS-21, a nicotinic acetylcholine agonist

Aug. 17, 1998

New cerebroprotective agents described by Japanese team

Aug. 17, 1998

Muscle-relaxant activity of silperisone: comparison with lidocaine

Aug. 14, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...